CRTX - Cortexyme to change name and ticker symbol next month
- Alzheimer’s drug developer Cortexyme ( NASDAQ: CRTX ) announced on Wednesday that the company would change its corporate name and ticker symbol with effect from August.
- Accordingly, Cortexyme ( CRTX ) will be branded as Quince Therapeutics next month, and its ticker symbol on the Nasdaq Global Select Market will change to “QNCX” at the market open on Aug. 01.
- Coinciding with the change, Quince Therapeutics is expected to issue a press release detailing its growth strategy and plans for the development pipeline.
- In addition, Quince’s new corporate website and social media profiles on Twitter and LinkedIn will launch on the same day.
- Seeking Alpha contributor Terry Chrisomalis points out that San Francisco, California-based biotech is pursuing a market opportunity worth $17.7B with its Alzheimer's candidate COR588.
For further details see:
Cortexyme to change name and ticker symbol next month